Purine analogues compared with mesalamine or 5-ASA for the prevention of postoperative recurrence in Crohn's disease: A meta-analysis

International Journal of Clinical Practice

Volumn 66, Issue 8, 2012, Pages 758-766

  Shen, F C ^a   Zhang, H J ^a   Zhao, X D ^a   Cao, R S ^a   Shi, R H ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE;

ABDOMINAL PAIN; ALOPECIA; AMYLASE BLOOD LEVEL; ANEMIA; ARTHRALGIA; ARTICLE; BONE MARROW TOXICITY; COLON SURGERY; CREATININE BLOOD LEVEL; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPY; FLATULENCE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; HUMAN; ILEUS; LEUKOPENIA; LYMPHOCYTOPENIA; MACROCYTIC ANEMIA; META ANALYSIS; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PANCREATITIS; PHLEBITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

EID: 84863900977     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02965.x     Document Type: Article

References (40)

1. Sale DJ, Kirsber JB,. The prognosis of inflammatory bowel disease. Arch Intem Med 1983; 143 (2): 294-9.
2. Farmer RG, Whelan G, Fazio VW,. Long-term follow-up of patients with Crohn's diease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88 (6): 1818-25. (Pubitemid 15052293)
3. Blum E, Katz JA,. Postoperative therapy for Crohn's disease. Inflamm Bowel Dis 2009; 15 (3): 463-72.
4. Ewe K, Böttger T, Buhr HJ, et al., Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999; 11 (3): 277-82. (Pubitemid 29286681)
5. Hellers G, Cortot A, Jewell D, et al., Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. IOIBD Budesonide Study Group Gastroenterol 1999; 116 (2): 294-300. (Pubitemid 29055351)
6. Bergman L, Krause U,. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease. Scand J Gastroenterol 1976; 11 (7): 651-6.
7. Rutgeerts P, Van Assche G, Vermeire S, et al., Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005; 128 (4): 856-61. (Pubitemid 40523538)
8. Caprilli R, Andreoli A, Capurso L, et al., Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Aliment Pharmacol Ther 1994; 8 (1): 35-43. (Pubitemid 24208226)
9. Brignola C, Cottone M, Pera A, et al., Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995; 108 (2): 345-9.
10. McLeod RS, Wolff BG, Steinhart AH, et al., Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109 (2): 404-13.
11. Hanauer SB, Korelitz BI, Rutgeerts P, et al., Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127 (3): 723-9. (Pubitemid 39208405)
12. Rutgeerts P, Hiele M, Geboes K, et al., Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108 (6): 1617-21.
13. Sutherland LR, Martin F, Bailey RJ, et al., A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. Gastroenterology 1997; 112 (4): 1069-77. (Pubitemid 27157516)
14. Ardizzone S, Maconi G, Russo A, et al., Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006; 55 (1): 47-53. (Pubitemid 41820634)
15. Yamamoto T,. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005; 11 (26): 3971-9. (Pubitemid 41235590)
16. Rutgeerts P, Geboes K, Vantrappen G, et al., Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99 (4): 956-63. (Pubitemid 20338451)
17. Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al., Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104 (8): 2089-96.
18. Ardizzone S, Maconi G, Sampietro GM, et al., Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004; 127 (3): 730-40. (Pubitemid 39208406)
19. Nos P, Hinojosa J, Aguilera V, et al., Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease. Gastroenterol Hepatol 2000; 23 (8): 374-8. (Pubitemid 32049690)
20. Herfarth H, Tiaden C, Lukas M, et al., Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006; 55 (10): 1525-6. (Pubitemid 44476806)
21. Reinisch W, Angelberger S, Petritsch W, et al., Azathioprine versus mesalamine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 2010; 59 (6): 752-9.
22. Kim DU, Kim YH, Kim BJ, et al., The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease. Hepatogastroenterology 2009; 56 (94-95): 1395-402.
23. Tiede I, Fritz G, Strand S, et al., CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003; 111 (8): 1133-45. (Pubitemid 36519931)
24. Baumgart DC, Vierziger K, Sturm A, et al., Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Scand J Gastroenterol 2005; 40 (8): 958-64. (Pubitemid 41117021)
25. D'Haens GR, Vermeire S, Van Assche G, et al., Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology. 2008; 135 (4): 1123-9. Epub 2008 Jul 16.
26. Calabrese E, Petruzziello C, Onali S, et al., Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009; 15 (11): 1635-42.
27. Domènech E, Mañosa M, Bernal I, et al., Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008; 14 (4): 508-13. (Pubitemid 351571830)
28. McLeod RS, Wolff BG, Ross S, et al., Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009; 52 (5): 919-27.
29. Scarpa M, Angriman I, Barollo M, et al., Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease. Hepatogastroenterology 2004; 51 (58): 1053-7. (Pubitemid 38822469)
30. Muñoz-Juárez M, Yamamoto T, Wolff BG, et al., Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum 2001; 44 (1): 20-5; discussion 25-6.
31. Tersigni R, Alessandroni L, Barreca M, et al., Does stapled functional end-to-end anastomosis affect recurrence of Crohn's disease after ileocolonic resection? Hepatogastroenterology 2003; 50 (53): 1422-5. (Pubitemid 37186499)
32. Ryan WR, Allan RN, Yamamoto T, et al., Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg 2004; 187 (2): 219-25. (Pubitemid 38183436)
33. Lochs H, Mayer M, Fleig WE, et al., Prophylaxis of postoperative relapse in Crohn's disease with Mesalamine: European cooperative Crohn's disease study VI. Gastroenterology 2000; 118 (2): 264-73. (Pubitemid 30067499)
34. Perfontaine E, Macdonald JK, Sutherland LR,. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2009; (4):CD000545. Update of Cochrane Database Syst Rev. 2000; (2): CD000545.
35. Perfontaine E, Sutherland LR, Macdonald JK, et al., Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009; (1):CD000067. Update of Cochrane Database Syst Rev. 2000; (2): CD000067.
36. Papay P, Reinisch W, Ho E, et al., The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery. Am J Gastroenterol 2010; 105 (5): 1158-64. Epub 2009 Dec 15.
37. Colombel JF, Sandborn WJ, Reinisch W, et al., Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362 (15): 1383-95.
38. Lémann M,. Review article: can post-operative recurrence in Crohn's disease be prevented? Aliment Pharmacol Ther 2006; 24 (Suppl. 3): 22-8. (Pubitemid 44326415)
39. Simon Travis,. Azathioprine for prevention of postoperative recurrence in Crohn's disease. EurJ Gastroenol Hepatol 2001; 13 (11): 1277-9.
40. Dignass AU, Baumgart DC, Sturm A,. Review article: the aetiopathogenesis of inflammatory bowel disease-immunology and repair mechanisms. Aliment Pharmacol Ther 2004; 20 (Suppl. 4): 9-17. (Pubitemid 39319241)